![Wenjin Yang](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Wenjin Yang
Directeur Technique/Scientifique/R&D chez
FORESEE PHARMACEUTICALS CO., LTD.
Profil
Wenjin Yang was the founder of Aldea Pharmaceuticals, Inc. founded in 2011, where he held the title of Officer from 2011 to 2014.
He is currently the Chief Scientific Officer at Foresee Pharmaceuticals Co., Ltd. since 2015.
Dr. Yang's former positions include Director & Head-Medicinal Chemistry at Sunesis Pharmaceuticals, Inc., Principal at Gilead Sciences, Inc., Vice President-Chemistry at Eiger BioPharmaceuticals, Inc., and Associate at The Scripps Research Institute.
Dr. Yang's education includes a graduate and doctorate degree from the University of California, Berkeley, an undergraduate and doctorate degree from National Taiwan University, and an undergraduate degree from Chinese Culture University.
Postes actifs de Wenjin Yang
| Sociétés | Poste | Début |
|---|---|---|
| FORESEE PHARMACEUTICALS CO., LTD. | Directeur Technique/Scientifique/R&D | 21/09/2015 |
Anciens postes connus de Wenjin Yang
| Sociétés | Poste | Fin |
|---|---|---|
Aldea Pharmaceuticals, Inc.
 Aldea Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel enzyme activators to enhance the removal of toxic aldehydes | Fondateur | - |
The Scripps Research Institute
 The Scripps Research Institute Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| VIRACTA THERAPEUTICS, INC. | Directeur/Membre du Conseil | - |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | - |
Eiger BioPharmaceuticals, Inc. /Old/
 Eiger BioPharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Corporate Officer/Principal | - |
Formation de Wenjin Yang
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
26
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Sunesis Pharmaceuticals, Inc.
 Sunesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology therapeutics for treatment of solid and hematologic cancers | Health Technology |
Eiger BioPharmaceuticals, Inc. /Old/
Eiger BioPharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Health Technology |
Aldea Pharmaceuticals, Inc.
Aldea Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel enzyme activators to enhance the removal of toxic aldehydes | Health Technology |
The Scripps Research Institute
The Scripps Research Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Taiwan University
 National Taiwan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chinese Culture University
 Chinese Culture University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Foresee Pharmaceuticals Co., Ltd.
 Foresee Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in pharmaceutical preparation | Health Technology |
